Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROY S HERBST

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1619060498
CMS profile
73386
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$586,663.99

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROY S HERBST

NPI 1619060498 · CMS profile ID 73386

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619060498?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROY S HERBST, NPI 1619060498, CMS profile ID 73386. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619060498?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ROY S HERBST, NPI 1619060498, CMS profile ID 73386. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619060498?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ROY S HERBST, NPI 1619060498, CMS profile ID 73386, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1619060498?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $586,663.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–125 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $66.9603/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105731827 CMS
AstraZeneca Pharmaceuticals LP $538.3703/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104628246 CMS
AstraZeneca Pharmaceuticals LP $374.1803/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104745525 CMS
AstraZeneca Pharmaceuticals LP $221.6403/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104764334 CMS
AstraZeneca Pharmaceuticals LP $221.6403/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105649868 CMS
AstraZeneca Pharmaceuticals LP $609.6903/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105879478 CMS
Merck Sharp & Dohme LLC $150.0003/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141658458 CMS
Merck Sharp & Dohme LLC $326.2102/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141663617 CMS
Regeneron Pharmaceuticals, Inc. $52.2802/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114400027 CMS
Merck Sharp & Dohme LLC $2,723.7502/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141827016 CMS
Merck Sharp & Dohme LLC $374.2202/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141572075 CMS
Merck Sharp & Dohme LLC $48.2702/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141572099 CMS
Merck Sharp & Dohme LLC $49.9502/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141572101 CMS
Merck Sharp & Dohme LLC $30.5202/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141827240 CMS
Merck Sharp & Dohme LLC $357.5002/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141572105 CMS
Merck Sharp & Dohme LLC $374.2202/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141572109 CMS
SANOFI US SERVICES INC. $2,895.0001/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139632047 CMS
Regeneron Pharmaceuticals, Inc. $2,376.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114400021 CMS
Regeneron Pharmaceuticals, Inc. $7,128.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114400023 CMS
Regeneron Pharmaceuticals, Inc. $2,376.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114400025 CMS
Regeneron Healthcare Solutions, Inc. $46.7901/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114068361 CMS
Immunocore Limited $15,407.5501/16/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103096657 CMS
Merck Sharp & Dohme LLC $710.9001/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141588280 CMS
Merck Sharp & Dohme LLC $328.8201/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141588282 CMS
Merck Sharp & Dohme LLC $355.3501/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141832501 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $108,344.56 111
PY2020 $44,591.50 21
PY2021 $63,817.49 32
PY2022 $85,730.00 50
PY2023 $495,399.67 83
PY2024 $586,663.99 125
PY2025 $545,879.40 136

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $8,036.07 7
PY2025 Principal investigator $276,786.81 6
PY2024 Principal investigator $325,456.12 13
PY2023 Principal investigator $324,273.53 34
PY2022 Principal investigator $384,367.90 32
PY2021 Recipient $4,783.86 4
PY2021 Principal investigator $467,371.88 23
PY2020 Recipient $26,879.51 22
PY2020 Principal investigator $623,063.44 51
PY2019 Principal investigator $760,056.01 43

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,528.75 12/31/2025 Non-covered Recipient Entity
Yale University
A Phase 3 Randomized, Placebo controlled Study to Evaluate the Safety and Efficacy of Pemetrexed Platinum Chemotherapy Pembrolizumab MK 3475 with or without Lenvatinib E7080,MK 7902 as First-line Intervention in Participants with Metastatic Nonsqu No dispute reported 06/30/2026 1232936560
Recipient F. Hoffmann-La Roche AG $1,143.94 12/11/2025 Covered Recipient Physician 1LM SCLC Tecentriq Lurbinectedin No dispute reported 06/30/2026 1211538694
Recipient F. Hoffmann-La Roche AG $781.10 12/11/2025 Covered Recipient Physician 1LM SCLC Tecentriq Lurbinectedin No dispute reported 06/30/2026 1211538698
Recipient F. Hoffmann-La Roche AG $3,691.13 11/27/2025 Covered Recipient Physician 1LM SCLC Tecentriq Lurbinectedin No dispute reported 06/30/2026 1211538690
Recipient F. Hoffmann-La Roche AG $1,641.54 09/17/2025 Covered Recipient Physician 1LM SCLC Tecentriq Lurbinectedin No dispute reported 06/30/2026 1211538686
Principal investigator 1 AstraZeneca UK Limited $229.06 06/19/2025 Non-covered Recipient Entity
YALE NEW HAVEN HEALTH SYSTEM
A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST) No dispute reported 06/30/2026 1185545503
Principal investigator 1 AstraZeneca Pharmaceuticals LP $250,000.00 06/15/2025 Non-covered Recipient Entity
YALE SCHOOL OF MEDICINE DEPARTMENT OF ORTHOPAEDICS AMD REHABILITATION
Tagrisso Collaborations Yale Univ No dispute reported 06/30/2026 1185545501
Principal investigator 1 Genentech, Inc. $5,200.00 05/23/2025 Non-covered Recipient Entity
YALE UNIVERSITY SCHOOL OF MEDICINE
Atezolizumab with or without tiragolumab in 1L NSCLC No dispute reported 06/30/2026 1211686925
Principal investigator 1 Merck Sharp & Dohme LLC $13,000.00 05/21/2025 Non-covered Recipient Entity
Yale University
A Phase 3 Randomized, Placebo controlled Study to Evaluate the Safety and Efficacy of Pemetrexed Platinum Chemotherapy Pembrolizumab MK 3475 with or without Lenvatinib E7080,MK 7902 as First-line Intervention in Participants with Metastatic Nonsqu No dispute reported 06/30/2026 1232936558
Principal investigator 1 Genentech, Inc. $6,829.00 05/15/2025 Non-covered Recipient Entity
YALE UNIVERSITY
Atezolizumab with or without tiragolumab in 1L NSCLC No dispute reported 06/30/2026 1211685728
Recipient F. Hoffmann-La Roche AG $227.64 04/25/2025 Covered Recipient Physician Atezolizumab with or without tiragolumab in 1L NSCLC No dispute reported 06/30/2026 1211538679
Recipient F. Hoffmann-La Roche AG $330.27 03/31/2025 Covered Recipient Physician PH III OPEN LABEL STDY ATEZO VS PLATINUM PEMETREXED GEMCITABINE FOR PDL1 CHEMO NAIVE STG IV NSCLC No dispute reported 06/30/2026 1211538683
Recipient F. Hoffmann-La Roche AG $220.45 03/31/2025 Covered Recipient Physician Atezolizumab with or without tiragolumab in 1L NSCLC No dispute reported 06/30/2026 1211538703